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OBJECTIVE We compared the result of radiofrequency (RF)-assisted valvotomy and balloon dilation with
closed surgical valvotomy and Blalock Taussig (BT) shunt as primary treatment in selected
patients with pulmonary atresia and intact ventricular septum (PA-IVS).
BACKGROUND Patients with PA-IVS who have mild to moderate hypoplasia of the right ventricle (RV) and
patent infundiblum have the greatest potential for complete biventricular circulation. The use
of RF or laser wires to perforate the atretic valve followed by balloon dilation provides an
alternative to surgery.
METHODS Between May 1990 and March 1998, 33 selected patients underwent either percutaneous RF
valvotomy and balloon dilation (group 1, n 5 21; two crossed over to group 2) or surgical
valvotomy with concomitant BT shunt (group 2, n 5 14). Second RV decompression by
balloon dilation or right ventricular outflow tract (RVOT) reconstruction were performed if
necessary. Patients who remained cyanosed were subjected to transcatheter trial closure of the
interatrial communication. Partial biventricular repair was offered to those with inadequate
growth of the RV.
RESULTS The primary procedure was successful in 19 patients in group 1. There was one in-hospital
death and two late deaths. Of the remaining 16 survivors, 12 achieved complete biventricular
circulation, 7 of whom required no further interventions. Two patients required repeat
balloon dilation, 1 RVOT reconstruction and 2 transcatheter closure of interatrial commu-
nication. Two patients underwent partial biventricular repair. In group 2, there were 3
in-hospital deaths after the primary procedure and 1 patient died four months later. All
survivors (n 5 10) required a second RV decompression, 8 by balloon dilation and 2 by
RVOT reconstruction, after which, two patients died. Of the final 8 survivors, 7 achieved
complete biventricular circulation, 5 after coil occlusion of the BT shunt and 2 after closure
of interatrial communication.
CONCLUSIONS Radiofrequency valvotomy and balloon dilation is more efficacious and safe compared with
closed pulmonary valvotomy and BT shunt in selected patients with PA-IVS. (J Am Coll
Cardiol 2000;35:468–76) © 2000 by the American College of Cardiology
Pulmonary atresia with intact ventricular septum (PA-IVS)
is a relatively uncommon form of congenital heart disease
and is remarkable in its morphologic diversity, characterized
by varying degrees of right ventricle (RV) hypoplasia and
associated with tricuspid valve dysplasia and sinusoidal right
ventriculo-coronary connections (1–3). A single uniform
approach in the management of this disease is therefore
impractical.
It has increasingly been recognized that there are two
principal forms of this disease, those with mild to moderate
hypoplasia of the RV who generally have a patent infun-
dibulum, and those with severe hypoplasia of the RV who
positively correlate with major RV-coronary connections
(4). For patients in the first group, who incidentally form a
majority in most of the reported series, many authors believe
that the treatment goal is to eventually establish a complete
biventricular circulation with RV decompression as the
initial palliative procedure (5). On the other hand, patients
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with severely hypoplastic, diminutive RV are generally
assigned towards a univentricular repair, and in the difficult
subset of patients with RV-dependent coronary circulation,
cardiac transplantation may be an option. Right ventricle
decompression may be achieved by simple pulmonary val-
votomy without cardiopulmonary bypass, or by a more
radical transannular patch of the right ventricular outflow
tract (RVOT) in the neonatal period with or without a
concomitant systemic-pulmonary shunt. More recently, the
use of laser wire and radiofrequency (RF)-assisted valvot-
omy and balloon dilation has made possible primary treat-
ment of this group of patients to be undertaken in the
catheterization laboratory (6,7).
This study reviews the outcome of percutaneous RF
valvotomy and balloon dilation versus closed surgical val-
votomy and Blalock Taussig (BT) shunt in a selected group
of PA-IVS patients with mild to moderate RV hypoplasia
and patent infundibulum.
METHODS
Patient selection. We reviewed all patients with PA-IVS
who were referred to our institution from May 1990 to
March 1998. All patients underwent detailed echocardio-
graphic examination by two principal investigators (M.A.
and G.K.), paying particular attention to the size of the RV
and tricuspid valve compared with that of the LV and mitral
valve, respectively, presence or absence of RV infundibulum
and whether right ventriculo-coronary connections were
present. The degree of tricuspid regurgitation was assessed
by color flow in the apical four-chamber view based on the
ratio of maximum regurgitant area to the total right atrial
area as described by Fisher and Goldman (8). Grade 11 to
21 regurgitation was defined as mild, grade 31 as moderate
and grade 41 as severe. Apart from visual assessment of the
two-dimensional echocardiography (2DE) images, RV hy-
poplasia was defined as mild if the tricuspid/mitral diameter
ratio in the four-chamber view was .0.75; a ratio of 0.50 to
0.75 was considered moderate and a ratio of ,0.50 severe.
The diameter of tricuspid valve measured on 2DE and the
body surface area were used to compute the Z value using
the normogram of the Congenital Heart Surgeon Study
Group Protocol (CHSS) (9) from January 1996 onwards.
Thirty-three patients who had RV anatomy deemed favor-
able for biventricular circulation, i.e., mild or at most
moderate hypoplasia and patent infundibulum, were sub-
jected to percutaneous RF valvotomy and balloon dilation
(group 1: n 5 21, two of whom crossed over to group 2) or
to closed surgical valvotomy without cardiopulmonary by-
pass with a concomitant BT shunt (group 2: n 5 14) as the
primary procedure in an unrandomized fashion (Fig. 1).
Group 2 essentially formed a historical control as they
underwent the surgical procedure before the introduction of
the transcatheter technique, except for the two patients who
crossed over after unsuccessful attempt at percutaneous RF
valvotomy. Patients with diminutive, severely hypoplastic
RV and tricuspid valve as well as absence of RV infundib-
ulum were excluded from the present study and were
assigned for eventual single-ventricle repair. The rare pa-
tients with gross dilation of the RV with Ebstein’s malfor-
mation of the tricuspid valve and severe tricuspid regurgi-
tation were also excluded.
With the unusual exception of one patient who presented
at eight years of age, the majority (27/33, 81%) presented in
the newborn period. Three patients presented at three
months of age, 1 at seven months and 1 at one year.
Twenty-seven (81%) patients received prostaglandin E1
(PGE1) infusion before and during the primary procedure.
One patient had a small, restrictive ventricular septal defect
but was nevertheless included in the study, as the clinical
presentation and other echocardiographic features were
otherwise consistent with the diagnosis of PA-IVS.
Abbreviations and Acronyms
ASO 5 Amplatzer Septal Occluder
BT 5 Blalock Taussig
CVP 5 central venous pressure
PA-IVS 5 pulmonary atresia with intact ventricular
septum
PDA 5 patent ductus arteriosus
PFO 5 patent foramen ovale
PGE1 5 prostaglandin E1
RF 5 radiofrequency
RV 5 right ventricle
RVOT 5 right ventricular outflow tract
2DE 5 two-dimensional echocardiography
Figure 1. Right ventricular angiogram in the lateral projection
showing a well-developed trabecular component, patent infundib-
ulum and atretic pulmonary valve (arrow). Moderate tricuspid
regurgitation.
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Transcatheter primary procedure. Twenty-one patients
were subjected to RF valvotomy and balloon dilation, of
whom, two patients were later included in the surgical group
after unsuccessful procedure (group 1). All patients in group
1 underwent cardiac catheterization under general anesthe-
sia. The femoral artery and vein were cannulated percuta-
neously using 4F and 5F sheaths, respectively. Right
ventricle-dependent coronary circulation was first excluded
in all patients. Radiofrequency valvotomy was performed
using the HAT 300 generator and 0.018-in. cereblate wire
(Sulzer Osypka GmBH, Grenzach-Wyhlen, Germany) via
a 5F Judkins right catheter. After successful valvotomy, a
0.014-in. Flex coronary guidewire (ACS Hi-Torque;
Floppy II, Temeluca, California), and in the later cases
Crosswire (Terumo Corp., Tokyo, Japan), was passed an-
tegradely into the pulmonary artery. Procedural failure is
defined as inability to perforate the atretic valve with the RF
wire, and subsequent balloon dilation thus could not be
performed.
Earlier in the series, the flex coronary wire was routinely
snared in the main pulmonary artery and brought down into
the descending aorta for better support during balloon
dilation. Balloon dilation was performed sequentially using
2-mm and 4-mm coronary balloons (Schneider [Europe]
GmBH, Bulach, Switzerland) and finally 8- to 10-mm
Tyshak (NuMED; Cornwall, Ontario, Canada) valvulo-
plasty balloon. The right ventricular-to-aortic pressure ratio
was used as a hemodynamic index of the severity of RV
hypertension. Prostoglandin infusion was then gradually
weaned off after 48 h, and if the patient remained duct
dependent two weeks after the procedure or showed evi-
dence of ductal closure despite PGE1 infusion, a modified
BT shunt or stenting of the patent ductus arteriosus (PDA)
was put forward (adjunct procedure).
Surgical valvotomy. Fourteen patients, including the two
who had unsuccessful RF valvotomy, underwent closed
pulmonary valvotomy with a concomitant BT shunt via left
thoracotomy (group 2). Prostoglandin infusion was discon-
tinued 24 h after the surgery. None of these patients
underwent preliminary cardiac catheterization studies, ex-
cept the two patients who crossed over.
Echocardiographic examination chiefly looking at the
degree of residual RVOT obstruction was performed at 24 h
after the primary procedure and repeated as necessary during
the initial hospitalization.
Morbidity and mortality. The duration of hospital stay,
requirement for ventilatory and inotropic support, compli-
cations and mortality related to the primary procedure
between two groups were compared. Mortality within the
initial hospital stay was considered as in-hospital death, and
late death were patients who died during subsequent admis-
sions.
Follow-up. On follow-up, the degree of cyanosis, presence
of RV failure and echocardiographic observations on RV
growth, residual pulmonary stenosis and tricuspid regurgi-
tation were noted. Complete biventricular circulation was
considered to have been achieved if there was no clinical
cyanosis (SaO2 . 96%) and echocardiograhic features of at
most mild RV hypoplasia and absence of predominantly
right to left shunt across the interatrial communication on
color Doppler if it has not been closed surgically or by a
device.
Subsequent procedures. All survivors from both groups
were subjected to cardiac catheterization four to six months
after the primary procedure if significant RV outflow
obstruction remained on Doppler echo (peak systolic gra-
dient . 25 mm Hg). Balloon dilation was performed if the
stenosis was at valvar level, and likewise for RVOT recon-
struction for subvalvar obstruction. All survivors in group 2
who were deemed to have achieved complete biventricular
circulation underwent further cardiac catheterization at 18
to 24 months (mean 21 months) of age for coil occlusion of
the BT shunt. In both groups, for patients who remained
cyanosed after the primary procedure despite having no
significant RVOT obstruction (peak systolic gradient ,
25 mm Hg) but continued to have mild to moderate RV
hypoplasia, a trial closure of the interatrial communication/
patent foramen ovale (PFO) using a balloon catheter and
followed by Amplatzer Septal Occluder (ASO) device
(AGA Medical Corporation, Golden Valley, Minnesota)
was performed. If the systemic pressure dropped by more
than 20% of the baseline and/or central venous pressure
(CVP) increased to .15 mm Hg, the RV was considered
inadequate for complete biventricular circulation. The ASO
device was then removed and the patient was subjected to
partial biventricular repair, i.e., creation of bidirectional
Glenn’s shunt and closure of PFO. In patients who could
tolerate closure of the PFO using the ASO device, a
dobutamine challenge was then performed at incremental
doses of 5 and 10 mg/kg/min for 10 min each. If the
hemodynamics remained stable, the device was then re-
leased permanently and the patient was considered to have
achieved complete biventricular circulation.
Statistical analysis. The nonparametric Wilcoxon rank
sum test and the Mann-Whitney U test were used to
compare the continuous variables. Comparison of dichoto-
mous variables was made using the Fisher exact test.
Statistical significance was assumed at 5% level.
RESULTS
Table 1 summarizes patient characteristics and preinterven-
tional echocardiographic findings of both groups. The
median weight for patients in group 1 was 3.4 kg (range 2.0
to 18.0 kg) and 3.3 kg in group 2 (range 1.7 to 6.0 kg). None
of the patients had Ebstein’s anomaly, and tricuspid regur-
gitation varied from 0 in 5 to severe in 12. Two patients in
both groups, respectively, had right ventriculo-coronary
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connections noted on echocardiogram. There was no sig-
nificant difference in the characteristics of preinterventional
echocardiogram. Dimensions of the tricuspid valve were
measured in 17 of the 19 patients in group 1. The mean
tricuspid valve diameter was 11 6 2.6 mm (range 6 to
15 mm) and the mean Z value was –0.6 6 1.6 (range 24.0
to 11.5). Three patients had Z values of -3.0 and less. The
patients in group 2, however, did not have detailed mea-
surement of the tricuspid valve diameter and Z value.
Group 1. Percutaneous RF valvotomy was unsuccessful in
two patients (9%), and they were subjected to the standard
surgical procedure electively two and four days later. There
was no noticeable deterioration in their clinical condition or
hemodynamic status after cardiac catheterization. Marked
subvalvar muscular hypertrophy was noted in these two
patients, and the catheter tip could not be placed beneath
the atretic valve but instead was misdirected into the
intertrabecular recesses. In the remaining 19 patients in
whom the procedure was successful, the RV/aortic systolic
pressure ratio dropped from a mean of 1.69 6 0.66 (0.9 to
3.7) to 0.75 6 0.41 (0.3 to 1.9) (Fig. 2). The mean
procedure time was 126.1 6 34.8 min (range 60 to
190 min). Two patients remained on prostaglandin infusion
two weeks after the primary procedure. One of them
received a right modified BT shunt. The other patient
became severely cyanosed due to ductal closure despite
PGE1 infusion, and she underwent PDA stenting using a
3.5-mm Bard XT stent (C.R. Bard Ireland Ltd., Galway,
Ireland). The stent was found to be thrombosed three
months later despite maintenance of aspirin, but the patient
remained pink as the RV compliance had improved by then.
In all survivors of the primary procedure, the transvalvar
Doppler gradient dropped to ,25 mm Hg and the RVOT
appeared wide open at a mean of 10 weeks of follow-up,
except in one patient whose transvalvar gradient remained
high (80 mm Hg). Repeat cardiac catheterization four
months later revealed subvalvar stenosis and a small pulmo-
nary annulus. She later underwent RVOT reconstruction
and closure of restrictive VSD. Three patients who attained
adequate RV decompression at the initial procedure, how-
ever, developed restenosis. In two patients, restenosis was
valvar, and both underwent successful balloon dilation six
months later. In one patient, the restenosis was subvalvar,
but the patient died suddenly 24 h after an otherwise
uneventful diagnostic cardiac catheterization.
COMPLICATIONS AND MORTALITY. The total mortality in
group 1 was 15.7%. (Table 2). One patient died 3 h after a
successful RF valvotomy and RV decompression due to
uncontrolled retroperitoneal hemorrhage. This was pre-
sumed to have originated from iliac artery trauma during the
arterial cannulation. Perforation of the RV outflow tract by
the RF wire was seen in three patients, resulting in self-
limiting small hemopericardium. Supraventricular tachycar-
dia with hypotension occurred in two patients during the
procedure, and both responded well to direct current car-
dioversion. One patient presented with femoral vein throm-
bosis one week after a successful procedure, which resolved
with heparin infusion. Late deaths were seen in two pa-
tients. One death was due to fulminant staphylococcal sepsis
four months after a successful primary procedure. Another
had an unexplained sudden death 24 h after an uneventful
Figure 2. Right ventricular-aorta systolic pressure ratio before and
immediately after RF valvotomy and balloon dilation, and during
subsequent cardiac catheterization in 19 patients from group 1.
One patient was in critical condition at the beginning of the
procedure and the initial RV pressure was not available (triangles).
Patients with subvalvar stenosis (squares). Patients who under-
went repeat balloon dilation (circles). Transvalvar Doppler gradi-
ent dropped to , 25 mm Hg at 10 weeks of follow-up (plus
signs).
Table 1. Patient Data and Preinterventional
Echocardiographic Findings
Patient Data Group 1 Group 2 p
No. of patients 19 14
Median age at diagnosis in
days (range)
6 (1–8 yrs) 1 (1–48) 0.09
Gender
Female 8 6 NS
Male 11 8
Median weight in kg
(range)
3.4 (2–18) 3.3 (1.7–6) 0.3
Echocardiography
Ebstein’s malformation
No 19 14 NS
Yes 0 0
Tricuspid regurgitation
Nil 2 3 NS
Mild 5 0
Moderate 3 8
Severe 9 3
R ventriculo-coronary
connections
Absent 17 12 NS
Present 2 2
RV hypoplasia
Mild 11 8 NS
Moderate 6 6
Severe 2 0
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diagnostic cardiac catheterization. The patient had subval-
var RV outflow obstruction with a RV systolic pressure of
100 mm Hg.
FOLLOW-UP AND LATE OUTCOME. All the survivors (16/19)
were followed up for a minimum of six months after the
primary procedure, with a mean of 18 months (6 to 36
months). Twelve patients achieved complete biventricular
circulation, seven of whom required no further interven-
tions. Of the remaining five patients, two underwent repeat
balloon dilation for restenosis and another underwent
RVOT reconstruction with concomitant closure of restric-
tive ventricular septal defect. These three patients were
considered to have attained complete biventricular circula-
tion. Another two patients attained complete biventricular
circulation after closure of PFO using the ASO device, 14
and 34 months, respectively, after the primary procedure.
This eliminated the cyanosis without impairment of the
cardiac output. One of these patients underwent coil occlu-
sion of the ductus arteriosus as well.
Two other patients attained reasonable RV growth (Z
10.6 and 10.1, respectively), albeit with mild cyanosis, but
the parents are hesitant for transcatheter closure of the
PFO.
Two of the 16 patients (12.5%) in group 1 failed to
achieve complete biventricular circulation. The Z values of
the tricuspid valve were -3.5 and -4.0 at initial presentation.
They both received bidirectional Glenn’s shunt and closure
of the PFO at six and eight months after the primary
procedure.
In one patient, who was severely cyanosed at eight
months post-RF valvotomy due to poor RV growth (Z 5
23.4), trial closure of PFO eliminated the cyanosis but
resulted in hypotension and elevated CVP after 10 min, and
the device was then removed. However, at 18 months,
despite surgical closure of the PFO at the time of the
Glenn’s shunt construction, he still had bidirectional shunt-
ing through a residual interatrial communication. It was
successfully occluded with an ASO device (Fig. 3). In the
other patient, trial closure was not undertaken, as the RV
was deemed too small (Z 5 26) to support the pulmonary
circulation (Fig. 4).
Group 2. COMPLICATIONS AND MORTALITY. The overall
mortality was significantly higher in group 2 (42.8%; p 5
0.04) (Table 2). Of the 14 patients in the surgical group,
there were three in-hospital deaths after the primary pro-
cedure, two due to RV failure at 13 and 36 postoperative
days. Both of these patients crossed over from group 1 after
failure of percutaneous procedure due to the presence of
marked subvalvar muscular hypertrophy. One patient died
from pneumonia at the fifth postoperative day. One patient
died four months later from RV failure. All 10 survivors
required a second RV decompression procedure at 6 to 12
months after the primary surgical procedure due to inade-
quate relief of RVOT obstruction. Eight were by balloon
dilation and two by RVOT reconstruction. The mean
RV/aortic systolic pressure ratio before the second proce-
dure was 1.22 6 0.27 (Fig. 5). Another two patients died
from RV failure after the second RV decompression proce-
dure, one soon after surgery and the other 4 h after balloon
Table 2. Morbidity and Mortality
Group 1 Group 2 p
Median days of hospital
stay (range)
9 (2–24) 20 (6–47) 0.009
Median days of
ventilation (range)
0 (0–4) 5 (1–36) 0.0002
Median days of inotropic
support (range)
0 (0–2) 0 (0–30) 0.07
Deaths
In hospital 1 3
Late 2 3
Total (%) 3 (15.7) 6 (42.8) 0.18 Figure 3. Right ventricular-aortic systolic pressure ratio before and
after second RV decompression by balloon dilation in eight
patients from group 2.
Figure 4. Right ventricular angiogram in the lateral projection
eight months after RF valvotomy and balloon dilation. Unob-
structed RV outflow tract but relatively small right ventricle (Z
value 23.4). Closure of interatrial communication with ASO
eliminated the cyanosis with no deterioration of hemodynamics.
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dilation. Both of these patients presented in critical condi-
tion and the procedures were performed as an emergency.
Eight patients developed postoperative complications of
diaphragmatic paralysis, blocked shunt, wound infection
and pneumonia. One patient developed shunt-related left
pulmonary artery stenosis, and this was treated by placement
of a Palmaz stent (Johnson and Johnson, Interventional
Systems, Warren, New Jersey) intraoperatively 22 months
after the primary procedure. Hospital stay and requirements
for ventilatory support were significantly higher in group 2
(p 5 0.009 and p 5 0.0002, respectively, Table 2).
FOLLOW-UP AND LATE OUTCOME. The survivors (n 5 8) in
this group had been followed up for a mean of 51 6 20.3
months (33 to 96 months). Seven patients who were
deemed to have complete biventricular circulation had their
BT shunt occluded with Gianturco coils. Five patients did
not require any further intervention. Two patients under-
went transcatheter closure of the PFO at three and eight
years of follow-up. The remaining patient is awaiting BT
shunt occlusion and trial closure of PFO (Fig. 6)
DISCUSSION
The few reports on long-term survival of patients with
PA-IVS have shown that the outlook is relatively poor
(10,11). However, recent reports have emphasized improved
operative results in infants with this disease (12–14). This
has been attributed in part to a better understanding of right
ventricular morphology and its use in the selection of
Figure 5. Flow chart summarizing the procedures and outcome of patients in group 1.
Figure 6. Flow chart summarizing the procedures and outcome of patients in group 2.
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management strategy (5,15). Many authors would now
agree that patients with mild-to-moderate RV hypoplasia
and patent infundibulum are potential candidates for even-
tual biventricular circulation. In these patients, the goal of
the initial palliation is to decompress the RV and establish
forward flow, which, in turn, will promote growth of the RV
(4,14). Controversy still exists on the optimal form of RV
decompression and whether a systemic-pulmonary shunt
should be an integral part of the initial palliative procedure
(8,16–20).
While transannular patching provides the greatest possi-
bility of unobstructed forward flow from the RV, the
proponents for pulmonary valvotomy have argued that it
produces less ventricular damage and pulmonary regurgita-
tion (14). It can also be performed safely without cardio-
pulmonary bypass. Although it may not completely relieve
pulmonary outflow obstruction, a more radical RV outflow
reconstruction can be deferred to late infancy when the
morbidity and mortality risks can be expected to be lower.
Furthermore, in those patients whose residual obstruction is
chiefly at valvular level, nonsurgical reintervention by bal-
loon dilation offers a safe and effective alternative (21). This
has been our approach in eight patients in group 2.
Transcatheter primary procedure. Transcatheter valvot-
omy and balloon dilation offer a promising alternative as the
primary therapy in selected patients with PA-IVS. Perfora-
tion of the atretic pulmonary valve can be achieved using
laser guidewire or RF wire, and balloon dilation can then be
performed in the conventional way (6,7,22). The sharp, stiff
end of a coronary guidewire has been successfully used to
perforate the atretic pulmonary valve (23), but this tech-
nique has been rendered largely obsolete with the availabil-
ity of laser and RF wires. The use of laser-based methods
has the advantage of using the same guidewire to track the
balloon over once the valve has been perforated. In our
experience, however, once valvotomy has been achieved
with RF wire, the tiny perforation could be recrossed with
another guidewire for subsequent balloon dilation in all
cases. Furthermore, the risk to staff, limited portability and
considerable capital expense favor the use of the RF method
(7). Since its introduction, the technical skills for this
demanding procedure have improved, the indications have
become more precise and more centers have begun to use
this approach (24–26). Although this technique has been
used in patients with infundibular atresia and even those
with ventricular septal defect (27,28), it is clear that only
patients with membranous valvular atresia and a patent
infundibulum, in the setting of a non-RV-dependent cor-
onary circulation, should be considered for this procedure to
achieve the best results and avoid serious complications (26).
This subgroup of patients generally has a reasonably well-
developed RV and therefore the greatest potential for
biventricular circulation (4). The one early death in our
series was a result of a rare but nevertheless known compli-
cation of vessel cannulation in a newborn rather than
directly related to the procedure itself.
Assessment of RV size. There continues to be much
debate on the best method of assessing right ventricular size
and morphology. There are proponents of using complex
scoring of right ventricular size (16), a simple measurement
of tricuspid annulus diameter (16) or merely visual assess-
ment of how well formed the RV appears to be (17,26).
Although we began measuring the Z value of the tricuspid
valve in the later part of the study, we concur with Gibbs et
al. (26) that the latter, simplest approach is probably
sufficient for clinical decision making. Of all the survivors
from both groups, the RV has not appeared to grow despite
virtual elimination of outflow obstruction in two patients,
both of whom underwent percutaneous RF valvotomy as the
primary procedure. We speculate that this may have been in
part attributable to their late presentation (three and seven
months), and hence delayed decompression of the RV.
Their tricuspid valve diameter z values were 23.5 and 24.0
at presentation, respectively. However, all is not lost, as the
RV can still be incorporated into the circulation, albeit with
a reduced volume load, by performing a bidirectional
Glenn’s Shunt and closure of interatrial communication
(partial biventricular repair) (18).
Closure of interatrial communication. We have found
the ASO, which is retrievable, to be a useful device in
determining the potential for complete biventricular circu-
lation in patients who continue to remain cynosed due to
inadequate growth of the RV. In patients destined for
partial biventricular repair, closure of the PFO would lead to
an increase in the CVP and concomitant lowering of the
systemic arterial pressure. On the other hand, in those
patients whose RV is capable of supporting the entire
pulmonary circulation, cyanosis would be eliminated with-
out increasing the CVP and compromising the cardiac
output. The device can then be safely deployed perma-
nently. However, we feel that it is important to stretch the
capability of the RV by dobutamine stress before deploy-
ment.
Subgroup with concomitant subvalvar obstruction.
Fixed, subvalvular stenosis is part of the anatomic spectrum
of PA-IVS (19). In our experience, this was a cause of
failure of perforation of the valve in two patients due to
malpositioning of the guiding catheter and RF wire in the
intertrabecular recesses. These two patients ( Z 5 21.1 and
10.5), who were then subjected to the standard surgical
procedure, subsequently died of RV failure at 13 and 36
postoperative days. In retrospect, a more radical RVOT
reconstruction, albeit with a higher operative mortality risk,
would have been more appropriate. No doubt, the pro-
longed requirement for inotropic and ventilatory support
and eventual death due to inadequate RV decompression
have negatively skewed the surgical results significantly.
However, in another patient, the procedure was successful,
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and this has allowed the patient to grow to a reasonable size
when a radical RVOT reconstruction could be performed at
a lower risk.
Study limitations. As this study is partly retrospective, the
Z value of the tricuspid valve as a measure of the RV size
was not available in the historical, surgical control group.
Nevertheless, the other preintervention echocardiography
findings were similar in the two groups, and all patients
underwent initial evaluation and selection into the study by
the two principal investigators. Second, the majority of
patients in the surgical group did not undergo prior cardiac
catheterization to exclude RV-dependent coronary circula-
tion. Nonetheless, the two patients in whom right
ventriculo-coronary connections were noted on echocardi-
ography were among the survivors. Finally, the patients in
the surgical control group received their treatment in a
slightly earlier era, and in two patients who died early of RV
failure due to inadequate RV decompression, the choice of
surgical treatment may not have been appropriate. There-
fore, the morbidity and mortality rates and final outcome
may not be representative of current surgical results in
established institutions (16,18).
Conclusions. From our small series, we conclude that
primary treatment with RF valvotomy and balloon dilation
compared with surgical valvotomy in this selected group is
more efficacious in decompressing the hypertensive RV in
that only a small number required a second decompression
procedure. It is also associated with lower morbidity, as
indicated by lower requirement for ventilation and freedom
from potential complications of surgery. Stenting of the
PDA in patients requiring prolonged prostaglandin infusion
despite absence of significant residual RVOT obstruction,
coil occlusion of PDA and transcatheter closure of inter-
atrial communication later in those patients who have
attained adequate RV growth offers the exciting prospect
that a small number of these patients may be treated entirely
in the catheterization laboratory.
The infrequency with which this anomaly occurs makes it
difficult to draw strong conclusions from a single institution,
but our results argue for further investigation and applica-
tion of this technique.
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